期刊文献+

人巨细胞病毒融合表达载体的构建及鉴定 被引量:2

Construction of Recombinant Plasmid for Fusion Expression of Human Cytomegalovirus and Identification of Expressed Product
下载PDF
导出
摘要 目的构建含人巨细胞病毒(HCMV)gB680糖蛋白基因和突变的pp65蛋白基因(pp65m)的融合表达载体,并检测其在COS-7细胞中的表达。方法用PCR法从HCMV基因组中钓取gB680和pp65m蛋白基因,分别亚克隆入pMD18-T载体中,经酶切鉴定并测序后,构建真核表达载体pVAX1/gB680+pp65m,以ELISA法检测其在COS-7细胞中的瞬时表达。结果重组质粒含有gB680和pp65m融合基因,并能在COS-7细胞中表达。结论已成功构建了人巨细胞病毒融合表达载体,并可在真核细胞中表达。 Objective To construct the fusion expression vector containing the genes encoding gB680 glycoprotein and mutant pp65 (pp65m) protein of human cytomegalovirns (HCMV) and determine the expressed product in COS-7 cells. Methods Amplify gB680 and pp65m genes from genome of HCMV by PCR and subclone to vector pMD18-T respectively. After identification of the constructed recombinant plasmids by restriction analysis and sequencing, clone gB680 and pp65m genes into plasmid pVAX1. Transfect COS-7cells with the constructed eukaryofic expression vector pVAX1/gB680 + pp65m, and identify the expressed product by ELISA. Results The constructed eukaryotic expression vector contained gB680 and pp65m fusion gene and expressed in COS-7cells. Conclusion The recombinant plasmid for fusion expression of HCMV gene was successfully constructed and expressed in eukaryotic cells.
出处 《中国生物制品学杂志》 CAS CSCD 2007年第5期340-342,351,共4页 Chinese Journal of Biologicals
关键词 人巨细胞病毒 融合表达 真核细胞 Human cytomegalovirus (HCMV) Fusion expression Eukaryotic cells
  • 相关文献

参考文献4

  • 1Hasan UA,Abai AM,Harper DR,et al.Nucleic acid immunization:concepts and techniques associated with third generation vaccines.J Immunol Methods,1999,229(1):1-22.
  • 2Endresz V,Kari L,Berencsi K,et al.Induction of human cytomegalovirus(HCMV)-glycoproteinB(gB)-specific neutralizing antibody and phosphoprotein 65(pp65)-specificcy totoxic T lymphocyte responses by naked DNA immunization.Vaccine,1999,17(1):50-58.
  • 3Wills MR,Carmichael AJ,Mynard K,et al.The human cytotoxic T-lymphocyte(CTL) response to CMV is dominated by structural protein pp65:frequency,specificy,and T-cell receptor usage of pp65-specific CTL.J Virol,1996,70(11):7569-7579.
  • 4Gallez-Hawkins G,Lomeli NA,Li X,et al.Kinase-deficient CMV pp65 triggers a CMV pp65 specific T-cell immune response in HLA-A*0201.K^b transgenic mice after DNA immunization.Scand J Immunol,2002,55(6):592-598.

同被引文献6

  • 1J 萨姆布鲁克,E F 弗里奇,T 曼尼阿蒂斯.分子克隆实验指南[M].第2版.金冬雁,黎孟枫,侯云德,等译.北京:科学出版社,1992.
  • 2Gallez-Hawkins G, Lomeli NA, Li X, et al. Kinase-deficient CMV pp65 triggers a CMV pp65 specific T-cell immune response in HLA-A^* 0201. K^b transgenic mice after DNA immunization [J]. Scand J Immunol,2002,55:592-598.
  • 3Endresz V, Kari L, Berencsi K, et al. Induction of human cytomegalovirus (HCMV) -glycoproteinB (gB)-specific neutralizing antibody and phosphoprotein 65 (pp65)-specificcy totoxic T lymphocyte responses by naked DNA immunization [J]. Vaccine, 1999,17:50-58.
  • 4Endresz V,Kari L,Berencsi K,et al. Induction of human cytomegalovirus (HCMV) -glycoprotein B (gB)-specific neutralizing antibody and phosphoprotein 65 (pp65)-specificcy totoxic T lymphocyte responses by naked DNA immunization[J]. Vaccine, 1999,17 : 50-58.
  • 5Gallez-Hawkins G,Lomeli N A,LLi X,et al. Kinase-deficient CMV pp65 triggers a CMV pp65 specific T-cell immune response in HLA-A * 0201. K^b transgenic mice after DNA immunization[J]. Stand J Immunol,2002,55 : 592-598.
  • 6J萨姆布鲁克,E F弗里奇,T曼尼阿蒂斯著.金冬雁,黎孟枫,等译.分子克隆实验指南[M].第2版.北京;科学出版社,1992.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部